Verge genomics honored by goldman sachs for entrepreneurship

San francisco--(business wire)--verge genomics, a tech-enabled drug discovery company pioneering the use of artificial intelligence (ai) and human data to develop new drugs, announced today that goldman sachs (nyse:gs) is recognizing verge's chief executive officer and co-founder, alice zhang, as one of the most exceptional entrepreneurs of 2022 at its builders and innovators summit in healdsburg, california.
GS Ratings Summary
GS Quant Ranking